The Trump administration has come under scrutiny after awarding nearly $40 million in biosecurity contracts to a company linked to President Donald Trump’s elder sons. This move follows the family’s investment in the parent company of XpresTest, which is tasked with screening for Ebola and other infectious diseases. The contracts, which involve screening at U.S. airports and addressing disease outbreaks in the Democratic Republic of … Continue reading Trump Sons Exposed In Shocking Scheme Profiting From Ebola Crisis